This report aims to provide insights into the global market for cell harvesting. It provides valuable information on cell harvesting type, application, and end user. Details on regional markets for these segments are also presented in this report. In addition, leading players in the market are profiled to understand the strategies undertaken by them to be competitive in this market
The Cell Harvesting Market is projected to reach USD 5 324.5 Million by 2023 from USD 196.9 Million in 2017, at a CAGR of 8.7% during the forecast period.
Globally, the market is witnessing high growth due to factors such as rising investments in regenerative medicine and cell-based research, growth of the biopharmaceutical and biotechnology industry, and increasing incidence of chronic and infectious diseases.
Cell Harvesting Market segmentation:
- based on type
- based on application
- based on end-user
- based on regions.
Cell harvesting is the process of harvesting cells from the culture media during upstream and downstream bioprocessing. Cell harvesters are used extensively for the cell harvesting process and are compatible with a wide range of assays, including cell proliferation assays, receptor binding assays, and adherent cell assays.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209513544
The growing use of single-use bioprocessing containers is expected to hinder the growth of this market in the coming years.
The Major Players Operating in the Cell Harvesting Market:
Key players in the industry include PerkinElmer (US), Brandel (US), TOMTEC (US), Cox Scientific (UK), Connectorate (Switzerland), Scinomix (US), ADSTEC (Japan), and Terumo BCT (a part of Terumo Corporation) (Japan).
Over the last few decades, key players operating in this market are focusing on expansion to help companies increase its share in the market. For instance, PerkinElmer and the Genome Institute of Singapore opened a research laboratory in Singapore.
Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=209513544
Geographical Detailed Analysis for Cell Harvesting Market:
Geographically, the market has been studied for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
The market is dominated by North America, followed by Europe; however, the APAC region is expected to witness the highest growth rate during the forecast period. Increasing private and government funding for stem cell research in this region and growing expansion of key market players in emerging Asian countries are some of the factors driving the APAC market.
In 2016, the Australian government invested USD 79.6 million in regenerative medicine research and development. Moreover, the Indian government plans to invest up to USD 5 billion a year (from 2014) for the next five years, to boost the biotechnology sector in the country and make it a USD 100-billion industry by 2025. These initiatives will fuel the growth of the cell harvesting market in Asia Pacific region.
Cell harvesting is the process of harvesting cells from the culture media during upstream and downstream bioprocessing.
Cell harvesters are used extensively for the cell harvesting process and are compatible with a wide range of assays, including cell proliferation assays, receptor binding assays, and adherent cell assays.According to the new market research report “Cell Harvesting Market by Type (Manual, Automated), Application (Biopharmaceutical, Stem Cell Research), End User (Biotechnology, Biopharmaceutical Companies, Research Institute), and Region (North America, Europe, APAC, Row) – Global Forecast” published by MarketsandMarkets™, is expected to grow at a CAGR of 8.7% during the forecast period to reach USD 324.5 Million.Growth Drivers in Depth:Rising Investments in Regenerative Medicine and Cell-Based ResearchGrowth of the Biotechnology and Biopharmaceutical IndustryIncreasing Incidence of Chronic and Infectious DiseasesGrowth Opportunities in Emerging EconomiesRequest Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=209513544The manual cell harvesters segment dominated the marketOn the basis of type, segmented into manual and automated cell harvesters.
The manual cell harvesters segment accounted for the largest share of this market.
The high share of the manual harvesters segment can be attributed to their ease of use and low price as compared to automated harvesters.The biotechnology & biopharmaceutical companies segment dominated the Cell Harvesting MarketIn the end user, segmented into research institutes, biotechnology & biopharmaceutical companies, and other end users.
The biotechnology & biopharmaceutical companies segment accounted for the largest share of the cell harvesters market.
The high share of this segment can be attributed to the high prevalence of chronic diseases.
This market report also allows you to identify the future opportunity and growth rate of the leading segment based on regions and countries.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the cell harvesting system market include Argos Technologies Incorporation, Perkin Elmer, Inc., BRAND GmBh+ CO KG, Arthrex Inc., Avita Medical, Tomtec, Bertin Technologies, Terumo Corporation, Teleflex, Inc.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Cell Harvesting System Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/cell-harvesting-system-market/download-sampleMarket DynamicsThe prominent factors that are contributing to the growth of the cell harvesting system market include growing awareness about the benefits of regenerative medicines and stem-cell-based therapy, increasing funding for R D in stem cell therapy by government and private sectors.
Furthermore, factors such as the rising prevalence of chronic diseases such as cardiovascular ailments and growing stem cell transplants are expected to boost the demand for stem cell-based therapy resulting in the growth of the cell harvesting system market.
The trend for umbilical cord banking is expanding across the globe as the stored cord blood can be used in the future for the treatment of chronic diseases such as cancer.
This aspect is supporting the cell harvesting market.
